Mansoor Namazi
Overview
Explore the profile of Mansoor Namazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masoomi Z, Nasirian A, Namazi M, Zangiabadian M, Dayani A, Shahidi M, et al.
Heliyon
. 2024 Feb;
10(4):e25926.
PMID: 38404852
Objective: This study aimed to quantify the incidence of Contrast-induced nephropathy (CIN) in patients undergoing primary percutaneous coronary intervention (PPCI) due to acute ST-elevation myocardial infarction (STEMI). Methods: From April...
2.
Norouzi S, Khalaji A, Namazi M, Rezaei S, Behnoush A, Masoumi M
Egypt Heart J
. 2022 Nov;
74(1):81.
PMID: 36434413
Background: Inflammatory rheumatic diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc), can cause cardiovascular complications in many cases. This study aimed to compare the ventricular...
3.
Shadmanfar S, Masoumi M, Davatchi F, Akhlaghi M, Faezi S, Kavosi H, et al.
J Tehran Heart Cent
. 2022 May;
16(3):109-112.
PMID: 35633822
: Behcet's disease (BD) is a vasculitis with multisystem and multiorgan involvement. Cardiac involvement in BD is a rare complication with a poor outcome that manifests itself in different forms....
4.
Mashinchi B, Aryannejad A, Namazi M, Moradi S, Masoumi Z, Parsaei A, et al.
Mod Rheumatol Case Rep
. 2021 Sep;
7(1):117-121.
PMID: 34480174
Coronavirus disease 2019 (COVID-19) poses a substantial challenge for rheumatologists and rheumatologic patients. They are concerned about the reciprocal interaction between connective tissue diseases, such as systemic lupus erythematosus (SLE),...
5.
Solaymani-Dodaran M, Ghanei M, Bagheri M, Qazvini A, Vahedi E, Saadat S, et al.
Int Immunopharmacol
. 2021 Mar;
95:107522.
PMID: 33735712
Background: We examined the safety and efficacy of a treatment protocol containing Favipiravir for the treatment of SARS-CoV-2. Methods: We did a multicenter randomized open-labeled clinical trial on moderate to...
6.
Moini A, Soltani B, Taghavi Ardakani A, Moravveji A, Erami M, Rezaei M, et al.
Jundishapur J Microbiol
. 2015 Nov;
8(10):e27517.
PMID: 26587220
Background: Escherichia coli and Klebsiella pneumoniae are common human pathogens that cause a wide spectrum of infections. Antimicrobial resistance is a basic obstacle in the management of these infections which...
7.
Soltani B, Taghavi Ardakani A, Moravveji A, Erami M, Rezaei M, Moniri R, et al.
Jundishapur J Microbiol
. 2014 Dec;
7(9):e20025.
PMID: 25485071
Background: Nasal colonization of healthy children with Staphylococcus aureus is an important risk factor for different infections. Detection of colonized individuals with methicillin resistant S. aureus (MRSA) and its eradication...